0.83 USD
▲-0.02+2.90%
盘后 0.83 +2.00%
2026-08-03
市值
$3.08M
市盈率
—
EPS
-300.31
股息率
—
52 周区间
0.67 – 209.50
成交量
163.67K
Beta
2.68
目标价
—
52W 低 0.6752W 高 209.50
价格走势
公司简介
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Bl...